These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7084476)
1. Platelet activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine). Activity of analogs lacking oxygen at the 2-position. Wykle RL; Surles JR; Piantadosi C; Salzer WL; O'Flaherty JT FEBS Lett; 1982 May; 141(1):29-32. PubMed ID: 7084476 [No Abstract] [Full Text] [Related]
2. Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils. Wykle RL; Miller CH; Lewis JC; Schmitt JD; Smith JA; Surles JR; Piantadosi C; O'Flaherty JT Biochem Biophys Res Commun; 1981 Jun; 100(4):1651-8. PubMed ID: 7295320 [No Abstract] [Full Text] [Related]
3. The enantiomer and the positional isomer of platelet-activating factor. Tence M; Coëffier E; Polonsky J; Benveniste J Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744 [TBL] [Abstract][Full Text] [Related]
4. 1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. O'Flaherty JT; Wykle RL; Miller CH; Lewis JC; Waite M; Bass DA; McCall CE; DeChatelet LR Am J Pathol; 1981 Apr; 103(1):70-8. PubMed ID: 7223864 [TBL] [Abstract][Full Text] [Related]
5. Stimulation and desensitization of human and rabbit platelets by 1-O-hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine and analogues. Ostermann G; Kertscher HP; Lang A; Till U Thromb Res; 1986 Sep; 43(6):675-80. PubMed ID: 3764811 [No Abstract] [Full Text] [Related]
6. 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) stimulates calcium influx in rabbit platelets. Lee TC; Malone B; Blank ML; Snyder F Biochem Biophys Res Commun; 1981 Oct; 102(4):1262-8. PubMed ID: 6797422 [No Abstract] [Full Text] [Related]
7. Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine. Namm DH; Tadepalli AS; High JA Thromb Res; 1982 Feb; 25(4):341-50. PubMed ID: 7071810 [TBL] [Abstract][Full Text] [Related]
8. Neutrophil responses to platelet-activating factor. O'Flaherty JT; Miller CH; Lewis JC; Wykle RL; Bass DA; McCall CE; Waite M; DeChatelet LR Inflammation; 1981 Sep; 5(3):193-201. PubMed ID: 7298160 [TBL] [Abstract][Full Text] [Related]
9. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712 [TBL] [Abstract][Full Text] [Related]
10. 1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes. Satouchi K; Oda M; Saito K Lipids; 1987 Apr; 22(4):285-7. PubMed ID: 3110532 [TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor and analogues: comparative studies with human neutrophils and rabbit platelets. O'Flaherty JT; Salzer WL; Cousart S; McCall CE; Piantadosi C; Surles JR; Hammett MJ; Wykle RL Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):291-309. PubMed ID: 6844746 [TBL] [Abstract][Full Text] [Related]
12. Influence of alkyl ether chain length of acetyl glyceryl ether phosphorylcholine and its ethanolamine analog on biological activity toward rabbit platelets. Satouchi K; Pinckard RN; Hanahan DJ Arch Biochem Biophys; 1981 Oct; 211(2):683-8. PubMed ID: 7305392 [No Abstract] [Full Text] [Related]
13. [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group]. Kertscher HP; Ostermann G Pharmazie; 1987 Nov; 42(11):713-5. PubMed ID: 3438334 [TBL] [Abstract][Full Text] [Related]
14. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues. Ostermann G; Kertscher HP; Till U Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829 [TBL] [Abstract][Full Text] [Related]
15. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. McManus LM; Hanahan DJ; Demopoulos CA; Pinckard RN J Immunol; 1980 Jun; 124(6):2919-24. PubMed ID: 7373056 [No Abstract] [Full Text] [Related]
16. Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues. Renooij W; Snyder F Biochim Biophys Acta; 1981 Feb; 663(2):545-56. PubMed ID: 6260215 [TBL] [Abstract][Full Text] [Related]
17. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation. Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936 [TBL] [Abstract][Full Text] [Related]
18. Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain. Surles JR; Wykle RL; O'Flaherty JT; Salzer WL; Thomas MJ; Snyder F; Piantadosi C J Med Chem; 1985 Jan; 28(1):73-8. PubMed ID: 4038418 [TBL] [Abstract][Full Text] [Related]
19. Antiplatelet activity of some prenylflavonoids. Lin CN; Shieh WL; Ko FN; Teng CM Biochem Pharmacol; 1993 Jan; 45(2):509-12. PubMed ID: 8435100 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of some structural analogs of platelet-activating factor (PAF-acether). Ténce M; Michel E; Coeffier E; Polonsky J; Godfroid JJ; Benveniste J Agents Actions; 1981 Dec; 11(6-7):558-9. PubMed ID: 7340440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]